Merck Santé

Merck Santé is the French pharmaceutical subsidiary of the global science and technology group Merck KGaA, headquartered in Darmstadt, Germany. The company maintains a significant industrial and clinical presence in France, operating several major production sites and research centers across the country. It is particularly renowned for its historical leadership in cardiometabolism, having developed the global standard-of-care diabetes treatment Glucophage (metformin). Beyond primary care, Merck Santé focuses on high-specialty therapeutic areas including oncology, neurology, and fertility. Key products in its portfolio include the monoclonal antibody Erbitux for colorectal and head and neck cancers, and Rebif for the treatment of multiple sclerosis. The French entity plays a crucial role in the parent company's global supply chain and R&D efforts, especially in biopharmaceutical manufacturing.